Profile
| Metric | Value |
|---|---|
| Full Name | Seres Therapeutics, Inc. |
| Ticker | NASDAQ: MCRB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | serestherapeutics.com |
| Employees | 103 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $8.87 | ||
| Price, 1D Change | -37.05% | |
| $80M | ||
| - | ||
| 14.61 | ||
| 1.06 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$18.86 | ||
| EPS, 1Y Change | -6.16% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$18.86 | ||
| EPS Estimate | $0.77 | |
| EPS Est. Change | +104.08% | |
| $0.00 | ||
| Revenue Estimate | $250.33K | |
| Revenue Est. Change | - | |
| $8.87 | ||
| Price Target | - | $21.00 |
| Price Tgt. Change | - | +136.75% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.99 | -$17.77 | -1,694.85% | |
| -$0.41 | -$18.86 | -4,515.51% | |
| $0.77 | N/A | +104.08% | |
| -$10.43 | N/A | +44.71% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $126.07M | $0.00 | -100.00% | |
| - | $0.00 | - | |
| $250.33K | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -45.78% | ||
| -91.82% | ||
| -43.30% | ||
| -88.18% | ||
| 0.00% | ||
| -100.00% | ||
| -6.16% | ||
| -2,537.90% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $8.87 | ||
| $14.57 | ||
| SMA 200 vs Price | +64.28% | |
| $15.52 | ||
| SMA 50 vs Price | +75.00% | |
| 1.06 | ||
| $0.99 | ||
| 42.64 | ||
| 72.99% | ||
| 108.48% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$18.86 | ||
| -$14.70M | ||
| - | ||
| -$121.32M | ||
| - | ||
| -$125.77M | ||
| - | ||
| -$120.30M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 6.65 | ||
| 0.94 | ||
| 0.94 | ||
| - | ||
| - | ||
| -12.40 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 14.61 | ||
| 228.61 | ||
| 1.84 | ||
| -1.21 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $13.78M | ||
| $30.79M | ||
| $139.81M | ||
| $38.67M | ||
| $126.03M | ||
| $41.22M | ||
| $91.64M | ||
| $8.67M | ||
| $4.08M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $121.32M | ||
| $117.78M | ||
| $14.70M | ||
| $53.18M | ||
| $5.47M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$148.61M | ||
| $142.29M | ||
| -$90.37M | ||
| $380.00K | ||
| -$148.99M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Canaccord Genuity | → | |
| Chardan Capital | → | |
| Chardan Capital | → | |
| Goldman Sachs | → | |
| Canaccord Genuity | → | |
| Chardan Capital | → | |
| JP Morgan | → | |
| Canaccord Genuity | → | |
| Chardan Capital | → | |
| Canaccord Genuity | → |
Analyst sentiment
Institutional ownership
Screeners with MCRB
FAQ
What is the ticker symbol for Seres Therapeutics, Inc.?
The ticker symbol for Seres Therapeutics, Inc. is NASDAQ:MCRB
Does Seres Therapeutics, Inc. pay dividends?
No, Seres Therapeutics, Inc. does not pay dividends
What sector is Seres Therapeutics, Inc. in?
Seres Therapeutics, Inc. is in the Healthcare sector
What industry is Seres Therapeutics, Inc. in?
Seres Therapeutics, Inc. is in the Biotechnology industry
What country is Seres Therapeutics, Inc. based in?
Seres Therapeutics, Inc. is headquartered in United States
When did Seres Therapeutics, Inc. go public?
Seres Therapeutics, Inc. initial public offering (IPO) was on June 26, 2015
Is Seres Therapeutics, Inc. in the S&P 500?
No, Seres Therapeutics, Inc. is not included in the S&P 500 index
Is Seres Therapeutics, Inc. in the NASDAQ 100?
No, Seres Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Seres Therapeutics, Inc. in the Dow Jones?
No, Seres Therapeutics, Inc. is not included in the Dow Jones index
When was Seres Therapeutics, Inc. last earnings report?
Seres Therapeutics, Inc.'s most recent earnings report was on November 5, 2025
When does Seres Therapeutics, Inc. report earnings?
The next expected earnings date for Seres Therapeutics, Inc. is March 12, 2026
Data Sources & References
- MCRB Official Website www.serestherapeutics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1609809/000119312525266011/0001193125-25-266011-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1609809/000095017025038427/0000950170-25-038427-index.htm
- MCRB Profile on Yahoo Finance finance.yahoo.com/quote/MCRB
- MCRB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mcrb